During the past decade, Universitätsmedizin Göttingen conducted 144 clinical trials. In the 10-year time frame, 144 clinical trials started and 37 clinical trials were completed, i.e. on average, 25.7% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 25 clinical trials were completed. i.e. 41% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsmedizin Göttingen" #1 sponsor was "University Medical Center Goettingen" with 12 trials, followed by "Boehringer Ingelheim" with 11 trials sponsored, "University of Ulm" with 10 trials sponsored, "German CLL Study Group" with 8 trials sponsored and "University of Göttingen" with 8 trials sponsored. Other sponsors include 190 different institutions and companies that sponsored additional 132 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsmedizin Göttingen" #1 collaborator was "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 11 trials as a collaborator, "University of Göttingen" with 6 trials as a collaborator, "University Medical Center Goettingen" with 5 trials as a collaborator, "AstraZeneca" with 4 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 4 trials as a collaborator. Other collaborators include 209 different institutions and companies that were collaborators in the rest 183 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsmedizin Göttingen" are "Heart Failure" (11 trials), "Lymphoma" (10 trials), "Atrial Fibrillation" (8 trials), "Chronic Lymphocytic Leukemia" (7 trials) and "Leukemia" (7 trials). Many other conditions were trialed in "Universitätsmedizin Göttingen" in a lesser frequency.

Most popular intervention types in "Universitätsmedizin Göttingen" are "Drug" (148 trials), "Device" (41 trials), "Procedure" (30 trials), "Biological" (26 trials) and "Other" (24 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "cyclophosphamide" (14 trials), "radiation therapy" (12 trials), "Cytarabine" (10 trials) and "filgrastim" (10 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsmedizin Göttingen" are 230 trials for "All" genders, 7 trials for "Male" genders and 6 trials for "Female" genders.

Currently, there are NaN active trials in "Universitätsmedizin Göttingen". undefined are not yet recruiting, 51 are recruiting, 30 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 118 completed trials in Universitätsmedizin Göttingen, 1 suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsmedizin Göttingen, 13 "Phase 1" clinical trials were conducted, 65 "Phase 2" clinical trials and 78 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 40 trials that are defined as “Not Applicable".

Universitätsmedizin Göttingen has several departments that took part in Clinical trials: "Herzzentrum Göttingen" - 7 trials, "Department of Gastroenterology, University Medical Center" - 5 trials, "Universitätsmedizin Göttingen, Klinik für Psychiatrie und Psychotherapie" - 4 trials, "Universitäts-Kinderklinik Päd. I, Hämatologie/Onkologie" - 2 trials, "Uni Göttingen, Georg-August-Universität; Klinik für Hämatologie und Medizinische Onkologie" - 6 trials, "Zentrum für Neurologische Medizin" - 2 trials, "Universitätsmedizin Göttingen Georg-August-Universität; Klinik für Urologie" - 2 trials, "Universitaetsklinikum Goettingen Zentrum Innere Medizin Abteilung Kardiologie und Pneumologie" - 2 trials, "Universitätsklinikum Göttingen, Institut für Pathologie" - 2 trials